Blood-Brain Barrier

When administering chemotherapy to a patient with recurrent glioblastoma, physicians must overcome the blood-brain barrier, an immunologic feature of the central nervous system.

A noninvasive focused ultrasound technology was used in an FDA-approved clinical trial to treat Alzheimer’s disease, according to a press release.

Surgeons at Lenox Hill Hospital are recruiting patients for a first-in-human, single arm, open-label phase 1 clinical trial investigating the safety and feasibility of using belly fat to treat recurrent glioblastoma.